aminocaproic acid has been researched along with Hepatic Failure in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sopher, M | 1 |
| Braunfeld, M | 1 |
| Shackleton, C | 1 |
| Busuttil, RW | 1 |
| Sangwan, S | 1 |
| Csete, M | 1 |
1 other study available for aminocaproic acid and Hepatic Failure
| Article | Year |
|---|---|
Fatal pulmonary embolism during liver transplantation.
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Hepatitis C; Humans; Liver Cirrhosis; | 1997 |